AsymBio to secure $184m to support growth in biologics manufacturing
Asymchem Group will contribute $156m while Hillhouse Qirui will invest nearly $26m.
Drug Development
Phylo and Chugai collaborate to deploy AI platform in drug discovery
FDA grants breakthrough therapy designation to Lilly’s olomorasib
Curium to acquire Lantheus in all-cash deal worth up to $8bn
IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib
Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy
miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies
Resilience and Lilly to increase US medicines production with $750m investment
